SCHEMBL16111115

SCHEMBL16111115

CC(C)C(Cl)c1ccc2c(c1)C(=O)C(=O)N2

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CES1 P23141 6/20 0.53
TGM2 P21980 5/20 0.53
ALDH1A1 P00352 1/20 0.49
MAOA P21397 8/20 0.45
MAOB P27338 8/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
CAPN9 O14815 1/20 0.44
CASP3 P42574 1/20 0.44
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4444879 0.83 TGM2 (0.55) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL5330038 0.79 TGM2 (0.53) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL11081844 0.76 MAOA (0.47) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL1767901 0.76 TGM2 (0.50) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL1768067 0.74 TGM2 (0.47) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL4967546 0.73 ALDH1A1 (0.55) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL28045892 0.72 MAOA (0.58) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL9114249 0.72 TGM2 (0.45) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL29657257 0.71 ROS1 (0.67) CES1TGM2ALDH1A1MAOAMAOB
SCHEMBL281743 0.71 ROS1 (0.67) CES1TGM2ALDH1A1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970183-A2 ISATIN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF DEGENERATIVE DISEASES AND DISORDERS Musc Foundation for Research Development (US) 2016-01-20 EP disclosed
WO-2014160143-A2 ISATIN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF DEGENERATIVE DISEASES AND DISORDERS MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2014-10-02 WO disclosed